催眠和认知行为疗法在胃肠道疾病管理中的应用。
Hypnosis and Cognitive Behavioral Therapies for the Management of Gastrointestinal Disorders.
机构信息
Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, P.O. Box 9126, Chapel Hill, NC, 27515, USA.
Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
出版信息
Curr Gastroenterol Rep. 2020 Jun 3;22(7):31. doi: 10.1007/s11894-020-00769-z.
PURPOSE OF REVIEW
To review the nature, current evidence of efficacy, recent developments, and future prospects for cognitive behavioral therapy (CBT) and gut-directed hypnotherapy, the two best established psychological interventions for managing gastrointestinal (GI) disorders.
RECENT FINDINGS
New large randomized controlled trials are showing that cost-effective therapy delivery formats (telephone-based, Internet-based, fewer therapist sessions, or group therapy) are effective for treating GI disorders. CBT and hypnotherapy can produce substantial improvement in the digestive tract symptoms, psychological well-being, and quality of life of GI patients. However, they have long been hampered by limited scalability and significant cost, and only been sufficiently tested for a few GI health problems. Through adoption of more cost-effective therapy formats and teletherapy, and by expanding the scope of efficacy testing to additional GI treatment targets, these interventions have the potential to become widely available options for improving clinical outcomes for patients with hard-to-treat GI disorders.
目的综述
回顾认知行为疗法（CBT）和肠道导向催眠疗法这两种治疗胃肠道（GI）疾病最有效的心理干预方法的性质、目前的疗效证据、最新进展和未来前景。
最近的发现
新的大型随机对照试验表明，具有成本效益的治疗提供方式（基于电话、基于互联网、较少的治疗师疗程或团体治疗）对治疗 GI 疾病有效。CBT 和催眠疗法可以显著改善 GI 患者的消化道症状、心理健康和生活质量。然而，它们长期以来一直受到可扩展性有限和成本高昂的限制，并且仅针对少数 GI 健康问题进行了充分测试。通过采用更具成本效益的治疗模式和远程治疗，并将疗效测试范围扩大到其他 GI 治疗目标，这些干预措施有可能成为改善治疗难治性 GI 疾病患者临床结果的广泛可用选择。
Zotero 插件